Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China Researchers Use Bioluminescence to Map Eye Cancer

publication date: Oct 14, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China researchers have shown that bioluminescence imaging (BLI) can be used to monitor tumors in the eye externally, without requiring an invasive biopsy. The new tools allow researchers to study the biology of retinoblastoma (RB) and offer the possibility of developing new therapies for RB. The investigation was carried out by a team of researchers at the First People’s Hospital in Shanghai, China, led by Qian Huang, MD, PhD, and reported in the peer-reviewed journal Investigative Ophthalmology & Visual Science. More details...



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors